TNSN07233A1 - Macrolides - Google Patents
MacrolidesInfo
- Publication number
- TNSN07233A1 TNSN07233A1 TNP2007000233A TNSN07233A TNSN07233A1 TN SN07233 A1 TNSN07233 A1 TN SN07233A1 TN P2007000233 A TNP2007000233 A TN P2007000233A TN SN07233 A TNSN07233 A TN SN07233A TN SN07233 A1 TNSN07233 A1 TN SN07233A1
- Authority
- TN
- Tunisia
- Prior art keywords
- des
- composés
- pour
- les
- est
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Tires In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Des composés macrolides proprement dits, représentés ci-dessous et définis dans le présent mémoire, et leur utilisation, par exemple comme agents antibactériens et antiprotozoaires chez des animaux, y compris les êtres humains : formule (I). Il est révélé également des procédés pour la préparation des composés, des intermédiaires, des compostions pharmaceutique contenant ces composés, et des méthodes pour le traitement et la prévention d'une maladie en administrant les composés à des sujets en ayant besoin. Cet abrégé est seulement un extrait et ne limite pas la présente invention.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63809704P | 2004-12-21 | 2004-12-21 | |
US71753005P | 2005-09-14 | 2005-09-14 | |
PCT/IB2005/003829 WO2006067589A1 (fr) | 2004-12-21 | 2005-12-12 | Macrolides |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN07233A1 true TNSN07233A1 (fr) | 2008-11-21 |
Family
ID=35809765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2007000233A TNSN07233A1 (fr) | 2004-12-21 | 2007-06-20 | Macrolides |
Country Status (35)
Country | Link |
---|---|
US (1) | US7462600B2 (fr) |
EP (2) | EP1836211B1 (fr) |
JP (1) | JP4111994B1 (fr) |
KR (1) | KR100897678B1 (fr) |
CN (1) | CN101120011A (fr) |
AP (1) | AP2007004026A0 (fr) |
AR (1) | AR052824A1 (fr) |
AT (1) | ATE459633T1 (fr) |
AU (1) | AU2005317735B2 (fr) |
BR (1) | BRPI0519135A2 (fr) |
CA (1) | CA2591746A1 (fr) |
CR (1) | CR9202A (fr) |
DE (1) | DE602005019786D1 (fr) |
DK (1) | DK1836211T3 (fr) |
EA (1) | EA011281B1 (fr) |
ES (1) | ES2339871T3 (fr) |
GE (1) | GEP20094834B (fr) |
GT (1) | GT200500378A (fr) |
HN (1) | HN2005036113A (fr) |
HR (1) | HRP20100253T1 (fr) |
IL (1) | IL183661A0 (fr) |
MA (1) | MA29108B1 (fr) |
MX (1) | MX2007007598A (fr) |
NL (1) | NL1030713C2 (fr) |
NO (1) | NO20073367L (fr) |
PE (1) | PE20060948A1 (fr) |
PL (1) | PL1836211T3 (fr) |
PT (1) | PT1836211E (fr) |
SI (1) | SI1836211T1 (fr) |
TN (1) | TNSN07233A1 (fr) |
TW (1) | TW200626608A (fr) |
UA (1) | UA85937C2 (fr) |
UY (1) | UY29285A1 (fr) |
WO (1) | WO2006067589A1 (fr) |
ZA (1) | ZA200705108B (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8367669B2 (en) * | 2005-06-15 | 2013-02-05 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
US9133212B1 (en) | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
JP5395432B2 (ja) | 2005-08-24 | 2014-01-22 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
DE602008001611D1 (en) * | 2007-03-13 | 2010-08-05 | Pfizer Prod Inc | Makrolide auf erythromycinbasis |
WO2008115118A1 (fr) * | 2007-03-21 | 2008-09-25 | Innate Pharmaceuticals Ab | Procédé et moyens pour prévenir et inhiber une sécrétion de type iii dans des infections provoquées par une bactérie à gram-négatif |
EP2220104A1 (fr) * | 2007-10-25 | 2010-08-25 | Sandoz AG | Procédé de fabrication de télithromycine |
AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
RU2495878C2 (ru) | 2007-12-21 | 2013-10-20 | Ф.Хоффманн-Ля Рош Аг | Гетероциклические антивирусные соединения |
EP2464651B1 (fr) | 2009-08-13 | 2016-04-20 | Basilea Pharmaceutica AG | Nouveaux macrolides et leur utilisation |
CA2793884C (fr) * | 2010-03-22 | 2019-09-10 | Cempra Pharmaceuticals, Inc. | Formes cristallines d'un macrolide et leurs utilisations |
WO2012142125A2 (fr) | 2011-04-12 | 2012-10-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibiteurs du canal anionique de surface de plasmodium pour le traitement ou la prévention de la malaria |
CN102558047B (zh) * | 2011-12-14 | 2013-10-30 | 天津药物研究院药业有限责任公司 | 3-甲基喹啉的制备方法 |
WO2013148891A1 (fr) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Formulations parentérales pour l'administration d'antibiotiques macrolides |
RU2015103119A (ru) | 2012-07-13 | 2016-08-27 | Ф. Хоффманн-Ля Рош Аг | Антипролиферативные бензо[в]азепин-2-оны |
KR101612179B1 (ko) * | 2013-04-19 | 2016-04-12 | 영남대학교 산학협력단 | 아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염을 유효성분으로 함유하는 암질환 예방 또는 치료용 약학조성물 |
TW201534586A (zh) | 2013-06-11 | 2015-09-16 | Orion Corp | 新穎cyp17抑制劑/抗雄激素劑 |
CN103739643A (zh) * | 2013-12-30 | 2014-04-23 | 华东理工大学 | 利用分子印迹技术对红霉素进行回收分离纯化的方法 |
CN104230891B (zh) * | 2014-08-27 | 2016-03-30 | 于宗光 | 一种托匹司他的制备方法 |
CN110234323A (zh) | 2016-10-04 | 2019-09-13 | Ti生物制药有限公司 | 具有抗菌活性的酮内酯 |
EP3972587A4 (fr) * | 2019-06-04 | 2023-01-18 | Hager Biosciences, LLC | Dérivés de pyrazole et d'imidazole, compositions et procédés en tant qu'antagonistes de l'orexine |
CN111793022A (zh) * | 2020-04-27 | 2020-10-20 | 滁州拜奥生物科技有限公司 | 一种3-甲基喹啉的制备方法 |
WO2024050061A2 (fr) * | 2022-09-01 | 2024-03-07 | Hager Biosciences, Llc | Dérivés de pyrazole et d'imidazole utilisés en tant que modulateurs des récepteurs double d'orexine et d'opioïdes kappa, composition, procédés de traitement de troubles neurologiques et psychiatriques |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653899A (en) | 1952-04-14 | 1953-09-29 | Lilly Co Eli | Erythromycin, its salts, and method of preparation |
US2823203A (en) | 1954-06-24 | 1958-02-11 | Abbott Lab | Method of producing substantially pure erythromycin a |
US4331803A (en) | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
US4742049A (en) | 1986-06-04 | 1988-05-03 | Abbott Laboratories | Semisynthetic erythromycin antibiotics |
US5075289A (en) | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
IE70593B1 (en) | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
US5523399A (en) | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
FR2697524B1 (fr) | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5527780A (en) | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5629322A (en) | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
FR2727969B1 (fr) | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
US5747466A (en) | 1995-11-08 | 1998-05-05 | Abbott Laboratories | 3-deoxy-3-descladinose derivatives of erythromycins A and B |
FR2742757B1 (fr) | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
EP0918783A1 (fr) | 1996-05-07 | 1999-06-02 | Abbott Laboratories | Erythromycines 6-o substituees et leur procede de preparation |
US5750510A (en) | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
FR2748746B1 (fr) | 1996-05-14 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine |
US6271255B1 (en) | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
FR2751656B1 (fr) | 1996-07-24 | 1998-10-16 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
ATE296832T1 (de) | 1996-09-04 | 2005-06-15 | Abbott Lab | 6-o-substituierte ketoliden mit antibakteriellen wirkung |
US5804565A (en) | 1996-09-24 | 1998-09-08 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
US6191118B1 (en) | 1996-11-27 | 2001-02-20 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
US6140479A (en) | 1997-03-24 | 2000-10-31 | Taisho Pharmaceuticals Co., Ltd. | Erythromycin a derivatives |
AU6932098A (en) | 1997-05-09 | 1998-12-08 | Pfizer Products Inc. | Erythromycin derivatives |
US20020025937A1 (en) | 2000-03-20 | 2002-02-28 | Yong-Jin Wu | 9-oxime erythromycin derivatives |
EP0895999A1 (fr) | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | Macrolides antibiotiques substitués C"-4 |
ZA987689B (en) | 1997-09-02 | 1999-02-24 | Abbott Lab | 3-descladinose 6-O substituted erythromycin derivatives |
US6034069A (en) | 1997-09-30 | 2000-03-07 | Abbott Laboratories | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
AU9649598A (en) | 1997-10-29 | 1999-05-17 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a, 11,12-carbamate derivatives |
HN1998000159A (es) | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
PA8461401A1 (es) | 1997-10-29 | 2000-05-24 | Pfizer Prod Inc | Derivados de eritromicina triciclicos |
AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
ES2226282T3 (es) | 1998-03-03 | 2005-03-16 | Pfizer Products Inc. | Antibioticos macrilidos de 3,6-cetal. |
US5955440A (en) | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
AU3439899A (en) | 1998-06-03 | 1999-12-20 | Pfizer Products Inc. | Tricyclic 3-keto derivatives of 6-o-methylerythromycin |
JP4573925B2 (ja) | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
US6020521A (en) | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
US6387885B1 (en) | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
US6262030B1 (en) | 1998-11-03 | 2001-07-17 | Pfizer Inc. | Erythromycin derivatives |
SK5812001A3 (en) | 1998-11-03 | 2001-12-03 | Pfizer Prod Inc | Novel macrolide antibiotics |
TR200102129T2 (tr) | 1998-12-10 | 2002-01-21 | Pfizer Products Inc. | Karbamat ve karbazat ketolid antibiyotikleri. |
CZ20012675A3 (cs) | 1999-01-27 | 2002-04-17 | Pfizer Products Inc. | Ketolidová antibiotika |
US6054435A (en) | 1999-03-19 | 2000-04-25 | Abbott Laboratories | 6-O-substituted macrolides having antibacterial activity |
MXPA01010521A (es) | 1999-04-16 | 2003-08-19 | Johnson & Johnson | Antibacteriales de cetolidos. |
US6395710B1 (en) | 1999-04-16 | 2002-05-28 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
US20020077302A1 (en) | 1999-04-23 | 2002-06-20 | Yong-Jin Wu | Tricyclic erythromycin derivatives |
US20020061857A1 (en) | 1999-04-23 | 2002-05-23 | Yong-Jin Wu | 9-amino-3-oxo erythromycin derivatives |
US6355620B1 (en) | 1999-05-14 | 2002-03-12 | Abbott Laboratories | C-2 modified erythromycin derivatives |
WO2000071557A1 (fr) | 1999-05-24 | 2000-11-30 | Pfizer Products Inc. | Derives de 13-methyl-erythromycine |
JP2001072669A (ja) | 1999-09-07 | 2001-03-21 | Showa Kako Kk | 7−クロロ−2,4(1h,3h)−キナゾリンジオンの製造方法 |
US6569836B2 (en) | 1999-12-02 | 2003-05-27 | Abbott Laboratories | 6-O-alkyl-2-nor-2-substituted ketolide derivatives |
EP1114826A3 (fr) | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Macrolides antibactériennes et prokinétiques |
EP1122261A3 (fr) | 2000-01-31 | 2001-09-26 | Pfizer Products Inc. | Macrolides antibactériennes à 13 ou 14 chainons |
JP2001261694A (ja) | 2000-03-06 | 2001-09-26 | Pfizer Prod Inc | ケトライド抗生物質 |
EP1146051A3 (fr) | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Dérivées de l' érythromycine A |
US20020061856A1 (en) | 2000-04-24 | 2002-05-23 | Yong-Jin Wu | Novel tricyclic erythromycin derivatives |
ATE271062T1 (de) | 2000-06-30 | 2004-07-15 | Pfizer Prod Inc | Makrolid-antibiotika |
US20020115621A1 (en) | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
HUP0302526A2 (hu) | 2000-12-21 | 2003-11-28 | Glaxo Group Limited | Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
US20020132782A1 (en) | 2001-01-18 | 2002-09-19 | Zhenkun Ma | 9-amino erythromycin derivatives with antibacterial activity |
WO2003004509A2 (fr) | 2001-07-03 | 2003-01-16 | Chiron Corporation | Macrolides et cetolides d'erythromycine modifiee c12 a activite antibacterienne |
US7064110B2 (en) | 2002-05-13 | 2006-06-20 | Enanta Pharmaceuticals, Inc. | 6-11 bicycle ketolide derivatives |
WO2005070918A1 (fr) | 2002-05-13 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | Procede de preparation de derives bicycliques 6-11 d'erythromycine |
WO2004094407A1 (fr) | 2003-04-21 | 2004-11-04 | Daiichi Pharmaceutical Co. Ltd. | Derive heterocyclique a cinq chainons |
EP1794171A2 (fr) | 2004-07-28 | 2007-06-13 | Ranbaxy Laboratories, Ltd. | Derives de cetolides agents antibacteriens |
WO2006046112A2 (fr) | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Derives de cetolides utiles comme agents antibacteriens |
GB0424951D0 (en) | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
US7419962B2 (en) | 2004-12-07 | 2008-09-02 | Enanta Pharmaceuticals, Inc. | 3,6-bicyclolides |
WO2006065743A2 (fr) | 2004-12-13 | 2006-06-22 | Enanta Pharmaceuticals, Inc. | Bicyclolides tetracycliques |
WO2006065721A2 (fr) | 2004-12-13 | 2006-06-22 | Enanta Pharmaceuticals, Inc. | Bicyclolides de 11, 12-lactone |
-
2005
- 2005-12-12 AP AP2007004026A patent/AP2007004026A0/xx unknown
- 2005-12-12 DK DK05813939.5T patent/DK1836211T3/da active
- 2005-12-12 WO PCT/IB2005/003829 patent/WO2006067589A1/fr active Application Filing
- 2005-12-12 AT AT05813939T patent/ATE459633T1/de not_active IP Right Cessation
- 2005-12-12 UA UAA200706959A patent/UA85937C2/uk unknown
- 2005-12-12 GE GEAP200510142A patent/GEP20094834B/en unknown
- 2005-12-12 CN CNA2005800482465A patent/CN101120011A/zh active Pending
- 2005-12-12 BR BRPI0519135-1A patent/BRPI0519135A2/pt not_active IP Right Cessation
- 2005-12-12 MX MX2007007598A patent/MX2007007598A/es active IP Right Grant
- 2005-12-12 EP EP05813939A patent/EP1836211B1/fr active Active
- 2005-12-12 KR KR1020077014160A patent/KR100897678B1/ko not_active IP Right Cessation
- 2005-12-12 PT PT05813939T patent/PT1836211E/pt unknown
- 2005-12-12 EP EP10154783A patent/EP2233493A1/fr not_active Withdrawn
- 2005-12-12 CA CA002591746A patent/CA2591746A1/fr not_active Abandoned
- 2005-12-12 AU AU2005317735A patent/AU2005317735B2/en not_active Ceased
- 2005-12-12 PL PL05813939T patent/PL1836211T3/pl unknown
- 2005-12-12 DE DE602005019786T patent/DE602005019786D1/de active Active
- 2005-12-12 JP JP2007547694A patent/JP4111994B1/ja not_active Expired - Fee Related
- 2005-12-12 EA EA200701113A patent/EA011281B1/ru not_active IP Right Cessation
- 2005-12-12 ES ES05813939T patent/ES2339871T3/es active Active
- 2005-12-12 SI SI200530941T patent/SI1836211T1/sl unknown
- 2005-12-14 PE PE2005001462A patent/PE20060948A1/es not_active Application Discontinuation
- 2005-12-19 HN HN2005036113A patent/HN2005036113A/es unknown
- 2005-12-20 GT GT200500378A patent/GT200500378A/es unknown
- 2005-12-20 AR ARP050105370A patent/AR052824A1/es unknown
- 2005-12-20 NL NL1030713A patent/NL1030713C2/nl not_active IP Right Cessation
- 2005-12-20 TW TW094145385A patent/TW200626608A/zh unknown
- 2005-12-21 US US11/313,523 patent/US7462600B2/en not_active Expired - Fee Related
- 2005-12-21 UY UY29285A patent/UY29285A1/es not_active Application Discontinuation
-
2007
- 2007-06-04 IL IL183661A patent/IL183661A0/en unknown
- 2007-06-15 ZA ZA200705108A patent/ZA200705108B/xx unknown
- 2007-06-20 TN TNP2007000233A patent/TNSN07233A1/fr unknown
- 2007-06-21 MA MA30024A patent/MA29108B1/fr unknown
- 2007-06-21 CR CR9202A patent/CR9202A/es not_active Application Discontinuation
- 2007-06-29 NO NO20073367A patent/NO20073367L/no not_active Application Discontinuation
-
2010
- 2010-05-04 HR HR20100253T patent/HRP20100253T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN07233A1 (fr) | Macrolides | |
TNSN06358A1 (fr) | Methyl-aryl-ou-heteroaryl-amides substitues | |
TNSN06051A1 (fr) | Derives de piperazine pour le traitement d'infections par le hiv | |
TNSN08196A1 (fr) | Derives de pyrazine | |
MA34361B1 (fr) | Dérivés de tétrahydro-pyrido-pyrimidine | |
TNSN06370A1 (fr) | Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
BR0207657A (pt) | Uma ou mais sequências de polinucleotìdeos isoladas, vetor, célula hospedeira, composição, disposição, métodos para diagnosticar as osteoartrites branda, moderada, acentuada e grave em um paciente, para identificar um agente que aumenta ou diminui a expressão de uma sequência de polinucleotìdeos, para preparar uma coleção de cdna de condrócito, e para fabricar uma disposição, e conjunto | |
TNSN07375A1 (fr) | Acides nucleiques de liaison a la ghreline | |
TNSN06359A1 (fr) | Aryl-ou heteroaryl-amides substitues en position ortho | |
TNSN07066A1 (fr) | Inhibiteurs de l'arn-polymerase, dependant d'arn, du virus de l'hepatite c, et compositions et traitements les utilisant | |
MA30988B1 (fr) | Composes destines a inhiber la progression mitotique | |
TNSN05073A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
MA30911B1 (fr) | Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine | |
MA31319B1 (fr) | Dérivés de sulfonylamides destines au traitement d'une croissance cellulaire anormale | |
MA27009A1 (fr) | Derives de pyrazole pour le traitement d'une infection par le vih | |
TNSN06075A1 (fr) | Phenyl-ou pyridylamides servant d'antagonistes de la prostaglandine e2 | |
WO2001081310A8 (fr) | 1-aroyle-piperidinyle benzamidines | |
TNSN08270A1 (fr) | Dérivés pyrimidiques destinés à traiter une croissance cellulaire anormale | |
MA30784B1 (fr) | Derives phenyliques et utilisation de ceux-ci en tant qu'immunomodulateurs. | |
MA28038A1 (fr) | Thienopyrazoles | |
MA34308B1 (fr) | Triazolopyridines substituées | |
MA27443A1 (fr) | Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
MA24729A1 (fr) | Macrolides nouveaux. | |
TN2009000551A1 (fr) | Nouveaux composes chimiques | |
MA29377B1 (fr) | Derives de la pyrimidine pour traitement de troubles a caractere hyperproliferatif |